Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7221 p593
26 October 2002

This article
Reprint
Photocopy


News summary

 


Supplementary prescribing proposals win broad support for pharmacists

Broad support has been found for the introduction of supplementary prescribing on the National Health Service by pharmacists and nurses following a Medicines Control Agency consultation on the proposal (PJ, 17 April, p521).
Most respondents to the consultation favoured the introduction of supplementary prescribing, but 78 of the 765 replies received, including some from pharmacists, voiced objections in principle.

The proposed changes would allow prescription-only medicines to be prescribed by supplementary prescribers as part of an agreed clinical management plan for individual patients. Supplementary prescribers would be responsible for monitoring and assessing a patient’s progress, and prescribing medicines within the limits of that plan. Supplementary prescribers would have to accept clinical responsibility and professional accountability for their prescribing decisions and practice.

All medicines would be prescribable by supplementary prescribers except Controlled Drugs and unlicensed medicines outside paediatric care. It is proposed that all supplementary prescribers should be able to prescribe pharmacy and general sale list medicines in addition to POMs.

Although most respondents supported supplementary prescribing, many of them expressed reservations or concerns as well. Some concerns were centred on excluded medicines that organisations believed should be included. Few said that specific medicines or conditions should be excluded from the scheme. For example, the Royal College of Paediatrics and Child Health was disappointed that the exclusion of CDs meant that supplementary prescribers would be unable to choose rectal diazepam to terminate convulsions. A number of pharmacy organisations pointed out that the exclusion of all CDs meant that pharmacists would not be able to prescribe some products that they were legally entitled to sell.

However, most of the reservations and concerns were over the detail of training, drafting management plans and the specific roles and responsibilities of independent and supplementary prescribers.

Some respondents supported the introduction of supplementary prescribing, but regretted the fact that the proposal did not include their sectional interests, eg, dietitians, radiographers and physiotherapists.

Most objections to the principle of supplementary prescribing came from individual health professionals who believed that they should have full independent prescribing responsibilities or from doctors who believed that only they should be allowed to prescribe.

Six pharmacists out of 124 who responded to the consultation personally were opposed in principle to supplementary prescribing.

For a summary of the responses go to the PJOnline links page (www.pjonline.
com/links).

 

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal